Deccan Polypacks (531989)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Tiny ₹7 Cr market cap means even a small absolute profit improvement could produce large percentage gains if operations ever restart.
• Trailing P/E of 12.41 is not demanding by historical standards, though it is meaningless without current earnings.
• Packaging is a necessary basic industry; the business is not structurally obsolete, only currently inactive.
• Current price ₹8.62 is well below the 52-week high of ₹46.50, so the market already discounts severe distress.

Concerns

• Latest quarter sales are ₹0 Cr and net profit is ₹-0 Cr; profit growth is -100%.
• Piotroski F-Score of 2/9 signals very weak financial health and poor operating discipline.
• ROCE is 0.00%, ROE is 0.89%, and dividend yield is 0%; capital is earning nothing for shareholders.
• The price of ₹8.62 is below the stated 52-week low of ₹20.28, indicating either unreliable data or extreme distress.
• No book value, debt/equity, promoter holding, or FairStock score data leaves the balance sheet opaque.

AI Analysis

At ₹8.62, this is a ₹7 crore micro-cap. A 12.41 P/E looks cheap at first glance, but that is a trailing mirage: the latest quarter shows zero sales and a negligible loss, and profit growth is -100%. You cannot pay a P/E for earnings that have disappeared. A 12.41 multiple only makes sense if normalized earnings exist; they do not. The Piotroski score is 2/9, ROCE is 0.00%, ROE is a negligible 0.89%, and there is no dividend. This is not a business; it is a shell with a listing. Sales growth stands at 0.00%, and the latest quarter contributes nothing. The 52-week range of ₹20.28 to ₹46.50 makes the current ₹8.62 price especially disturbing—it is trading below the stated 52-week low. Either the data is unreliable or the market has marked this down for a reason. Benjamin Graham said the stock market is a voting machine; this one is voting no. In packaging, a competitive commodity industry, there is no moat. There is no pricing power, no scale, and no durable competitive advantage visible in these numbers. With sales at zero, I cannot even begin to estimate normalized earnings. Graham taught me to buy with a margin of safety; here, the absence of book value, debt, and promoter data removes any floor. I cannot calculate a price-to-book ratio or assess leverage because the data is not available. A P/E of 12.41 is a trap when earnings are gone. A share is not a lottery ticket; it is a claim on future cash flows, and I see none. Turnarounds seldom turn, and this has no signs of a genuine turnaround—only zero revenue, poor F-score, and no return on capital. I would rather watch from the sidelines. When the facts are insufficient, a pass is the wisest investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer